Broncus Holding Corp (2216) fair value: what the stock is really worth
As of Nov 13, 2026: fair value (intrinsic value) of Broncus Holding Corp stock HK$0.29, price HK$0.54, that is 47.0% below the price, quality 39 out of 100. Rating: strongly overvalued. The value is an estimate: none of our valuation models currently carries, it draws on revenue and assets compared with similar companies. Updated daily.
- Keep an eye on it?Free in your watchlist: 5 stocks without an account, 10 with one Yes, for free
Broncus Holding Corp
2216 · HKFar too expensive (fair value 47% below the price), weak company and falling price: meets none of the 3 rules.
What runs behind every stock
69 individual criteria per stock, every one traceable See the method →
Price vs Fair Value
White line = price, green steps = our fair value per fiscal year. As of Nov 10, 2026.
How to read this chart
60‑month range HK$0.4600 – HK$15.10 · fair‑value band HK$0.2147 – HK$0.3578 · the HK$0.5400 price screens above the HK$0.2862 fair value. Green steps = our fair value per fiscal year (point-in-time, no hindsight). As of Nov 10, 2026.
Every Wednesday you see whether Broncus Holding is on track or worth a review, plus price against fair value. Free, up to 3 stocks.
We send you a confirmation link. Unsubscribe with one click.
Company profile
Broncus Holding Corporation, a medical device company, focuses on the development and commercialization of interventional pulmonology medical devices in China and internationally.
Show moreShow less
The company offers InterVapor, a thermal vapor treatment system to treat chronic obstructive pulmonary disease (COPD); BroncAblate Radiofrequency Ablation System, a transbronchial interventional treatment product for lung cancer; BroncTarget Targeted Lung Denervation (TLD) Radiofrequency Ablation System for the treatment of acute COPD exacerbation management; H-Marker, a pulmonary surgical marker that can be used to mark the location of the lung nodule for positioning during surgical pneumonectomy; Mist Fountain, a disposable nebulizing micro-catheter for endoscope used for airway anaesthesia, precise antibacterial and anti-inflammatory, tuberculosis drug delivery, phlegm reduction and elimination, thoracic surgery staining location, etc.; and BroncTru, a disposable transbronchoscopic dilatation catheter.
It also provides navigation products, such as LungPoint Virtual Bronchoscopic Navigation, a computer-assisted image-based navigation software system; LungPoint Plus/Archimedes Lite, a real-time navigation within the airways for lung biopsy and other procedures; and LungPro System, an archimedes system.
In addition, the company offers diagnosis products, such as FleXNeedle, a multipurpose biopsy needle; Archimedes Sheath, a sterile single-use tube that provides a working channel during a bronchoscopic procedure; Archimedes Dilation Balloon, a sterile single-use flexible tube with a balloon at or near the distal tip that is inserted through the bronchoscope or sheath, and for used to dilate the target lung tissue of the bronchial tree; BioStarNeedle, a single use ultrasound-guided needle for retrieval of tissue samples; and Steerable Sheath, a steerable sheath adjustment handle and a working channel.
The company was incorporated in 2012 and is headquartered in Hangzhou, China.
Stock analysis
Broncus Holding Corp (2216) currently trades at HK$0.5400, while our estimate is HK$0.2862, 47% below the price, so the stock looks overvalued today.
Show more
Valuation
None of our valuation models currently carries for this company, usually because of losses or heavy investment. The estimate draws on revenue and assets compared with similar companies and is less precise than a model-based fair value.
Scenario range: HK$0.2147 (bear) to HK$0.3578 (bull), the price of HK$0.5400 sits above it. Bear and bull are the same models on cautious and optimistic assumptions, a range, not a price target.
Quality & growth
The Quality Score stands at 39/100 (below-average quality), in the Healthcare sector.
Weak Growth: Revenue is shrinking: the last year, the last three and the last five years are all negative.
Broncus Holding Corp reported revenue of 174K CNY in FY2025 versus 10.9M CNY in FY2021, a compound −64.4%/yr. Reported net income was −17.9M CNY in FY2025.
Key figures
Market cap HK$285M (≈ $36.3M) Micro · Return on equity −12.0% · Return on assets (EBIT) −15.2% (5-year average) · Operating margin −300% · Revenue growth (YoY) +99.0% · Free cash flow −10.0M CNY · Net cash 31.9M CNY.
Competitive moat
Our AI-assisted moat analysis scores the competitive advantage at 9 out of 100 (medium confidence).
What moves the price
The share trades about 80% below its 52-week high and 1% above its 52-week low, currently below its 200-day average.
For context, the median of 10 Healthcare peers we cover trades at 7% fair-value upside, at −47%, 2216 screens richer than that median.
Fair Value
Quality Score breakdown
It rates the business: profits, how they develop, real cash, balance sheet, investing and share count.
Revenue & earnings trend
2216 screens overvalued: fair value 47% below the price. Compare with Abbott Laboratories, →
Compare Broncus Holding Corp with another stock
Price, fair value, quality and upside side by side.
Peer GroupⓘHow this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.Medical Devices · 401 stocks
Valuation Multiplesvs Medical Devices median · lower = cheaper
Strength profile in five axes (Snowflake)
VALUE 0: the price sits above our fair-value range.
Context: sector, industry, market
- Is the Health Care sector expensive or cheap?
- P/E, EV/EBITDA and margins by industry (reference tables)
- Return on equity by industry
- Quality Score by industry
- Piotroski F-Score screener with fair value
- Undervalued stocks: Hong Kong Stocks
Values & ESG
Does this company touch areas you may want to avoid? The classification is inferred from sector and industry.
Similar stocks
10 more Medical Devices stocks, each showing price versus our Fair Value estimate.
| Stock | Price | Fair Value | vs Fair Value | Compare |
|---|---|---|---|---|
| Stryker Corporation SYK | $309.64 | $343.63 | +11% | vs 2216 |
| Boston Scientific Corporation BSX | $44.34 | $48.77 | +10% | vs 2216 |
| Shenzhen Mindray Bio-Medical Electronics Co 300760 | ¥179.40 | ¥197.34 | +10% | vs 2216 |
| DexCom, Inc DXCM | $83.33 | $91.66 | +10% | vs 2216 |
| STERIS plc STE | $264.32 | $281.90 | +7% | vs 2216 |
| GE HealthCare Technologies Inc GEHC | $83.02 | $69.92 | −16% | vs 2216 |
| Edwards Lifesciences Corporation EW | $107.15 | $81.94 | −24% | vs 2216 |
| Medtronic plc MDT | $102.86 | $74.90 | −27% | vs 2216 |
| Abbott Laboratories, ABT | $108.52 | $75.28 | −31% | vs 2216 |
| Koninklijke Philips N.V PHIA | €27.43 | €15.23 | −44% | vs 2216 |
Explore undervalued stocks
More undervalued Healthcare stocks →
Try a ready-made strategy
Pick a strategy and jump into the live analysis with that exact screen applied.
Discover tools
Frequently asked questions
Is Broncus Holding Corp (2216) overvalued or undervalued?
What is the fair value of 2216?
What is the quality score of 2216?
What is the price target for Broncus Holding Corp (2216)?
What is the Broncus Holding Corp stock forecast for 2026?
What is the intrinsic value of Broncus Holding Corp (2216)?
Is Broncus Holding Corp stock overvalued or undervalued in 2026?
Is fair value the same as the market price of 2216?
How much is Broncus Holding Corp worth?
What do the bullish and bearish scenarios say about 2216?
How solid is the balance sheet of Broncus Holding Corp (2216)?
How far is 2216 from its 52-week high?
Which stocks are comparable to Broncus Holding Corp?
Is Broncus Holding Corp stock attractive at the current price?
Is it still worth investing in stocks now?
What is the share price of Broncus Holding Corp (2216)?
What should I pay attention to with Broncus Holding Corp right now?
Key figures of Broncus Holding Corp
How large is the market capitalisation of Broncus Holding Corp (2216)?
What is the return on equity of Broncus Holding Corp (2216)?
What is the EBIT return on assets of Broncus Holding Corp (2216)?
What is the operating margin of Broncus Holding Corp (2216)?
How fast is revenue growing at Broncus Holding Corp (2216)?
How much free cash flow does Broncus Holding Corp (2216) generate?
How much net cash does Broncus Holding Corp (2216) hold?
Watch Broncus Holding Corp in the live analysis
One click puts Broncus Holding Corp on your watchlist: fair value and trend at a glance, plus comparison, the diversification check and the 27,000+ stock screener.
Watch for free →Zero risk: nothing is ever charged. Your watchlist is yours, with or without an account.